We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Shire Hits Impax, Watson With Suits Over Patents on ADHD Drug Intuniv
Shire Hits Impax, Watson With Suits Over Patents on ADHD Drug Intuniv
December 7, 2010
Shire has filed a patent-infringement lawsuit against generic-drug makers Impax Laboratories and Watson Pharmaceuticals in response to the companies’ applications to market a generic version of Shire’s attention deficit hyperactivity disorder (ADHD) drug Intuniv.